Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

72 results about "Sh groups" patented technology

Piperidine derivatives as NMDA receptor antagonists

The present invention relates to a compound of formula (I):
wherein: V and U are hydrogen, halogen, C1-C4 alkylamino, or together form a group that contains one or more heteroatoms, and that taken together with one or more:
    • (a) hydrogen atoms;
    • (b) carbon atoms;
    • (c) —CH═ groups;
    • (d) —CH2— groups; or
    • (e) additional heteroatoms of the same or different type;
or any combination thereof, form a 4-7 membered homocyclic or heterocyclic ring, wherein the homocyclic or heterocyclic ring may combine with the phenyl group to form a bicyclic ring, and wherein the homocyclic or heterocyclic ring or the bicyclic ring may contain one or more oxo, thioxo, amino, mercapto, trifluoromethyl, C1-C4 alkyl, ═S or —SH groups;
  • W: is —CO—, —CH2— or —CH2—(C1-C4 alkyl)-;
  • X: is —CO—;
  • Y: is —O—, C1-C4 alkylene, C1-C4 alkynylene, cycloalkylene, aminocarbonyl, —NH—, —N(C1-C4 alkyl)-, -C1-C4 alkylene-N(C1-C4 alkyl)-, —CH2O—, —CH(OH)— or —OCH2—;
  • Z: is hydrogen, halogen, nitro, amino, C1-C4 alkyl, C1-C4 alkoxy, cyano, trifluoromethyl, hydroxyl or carboxyl;
  • R1 and R2: are hydrogen, or together form a C1-C3 bridge; and
  • n and m: independently are 0-3, wherein n and m cannot each be 0;
  • or an optical antipode, racemate or pharmaceutically-acceptable salt thereof. The carboxylic acid amide derivatives of formula (I) are highly effective and selective antagonists of the NMDA receptor.
    Owner:UCB PHARMA SRL

    Non-specific reaction inhibitor, and method and kit for inhibiting non-specific reaction

    Provided is a non-specific reaction inhibitor for inhibiting the occurrence of any non-specific reaction associated with a measurement procedure in a simple and effective manner to achieve the accurate detection and quantification of a trace component (a target substance) in a sample in an immunoassay. The non-specific reaction inhibitor comprises a substance represented by formula (I) [wherein R1 and R2 together form a double bond between carbons to which R1 and R2 are respectively bound directly, or R1 represents a hydrogen atom and R2 represents a group formed by removing H from an SH-group-containing compound; B represents a carrier; and L represents a spacer arm moiety].
    Owner:PHC CORP

    Glutathione-detecting fluorescent probe

    [Problem] To provide the following: a novel fluorescent probe for detecting a compound, such as glutathione, that contains a —SH group; a detection method using said fluorescent probe; and a detection kit containing said probe.
    [Solution] A fluorescent probe for detecting a compound containing an —SH group, wherein the fluorescent probe comprises a compound represented by formula (I) or a salt thereof (In the formula, X represents Si(Ra)(Rb), Ge(Ra)(Rb), Sn(Ra)(Rb), C(Ra)(Rb), or O (wherein Ra and Rb each independently represent a hydrogen atom or alkyl group); R1 represents a hydrogen atom, or 1-4 identical or different substituents independently selected from the group consisting of a cyano group, alkyl group, carboxyl group, ester group, alkoxy group, amide group, and azide group, each of which may be optionally substituted; R2 represents a hydrogen atom, halogen atom, hydroxyl group, cyano group, or an alkyl group, alkynyl group, alkoxy group, aryl, or heteroaryl, each of which may be optionally substituted; R3 and R4 each independently represent a hydrogen atom or 1-3 identical or different substituents independently selected from the group consisting of a hydroxyl group, halogen atom, or an alkyl group, sulfo group, carboxyl group, ester group, amide group and azide group, each of which may be optionally substituted; R5, R6, R7 and R8 each independently represent a hydrogen atom or alkyl group, wherein, R5 or R6, respectively together with R3, may form a ring structure including the nitrogen atoms bonded thereto, or R7 or R8, respectively together with R4, may form a ring structure including the nitrogen atoms bonded thereto).
    Owner:THE UNIV OF TOKYO
    Who we serve
    • R&D Engineer
    • R&D Manager
    • IP Professional
    Why Eureka
    • Industry Leading Data Capabilities
    • Powerful AI technology
    • Patent DNA Extraction
    Social media
    Try Eureka
    PatSnap group products